SWK Holdings Corporation (SWKH)

Price$15.90

Favorite Metrics

Price vs S&P 500 (26W)9.07%

Price vs S&P 500 (4W)-2.95%

Market Capitalization$192.33M

P/E Ratio (Annual)15.00x

Indicated Dividend Yield (Annual)0.00%

All Metrics

P/CF (Annual)7.05x

Book Value / Share (Quarterly)$19.44

P/TBV (Annual)0.67x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-0.03%

Cash Flow / Share (Quarterly)$2.21

Price vs S&P 500 (YTD)-3.73%

Gross Margin (TTM)63.46%

Net Profit Margin (TTM)-6.11%

EPS (TTM)$-0.22

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-0.22

Revenue Growth (5Y)2.47%

EPS (Annual)$-0.21

Dividend / Share (Annual)$4.04

ROI (Annual)-0.95%

Gross Margin (Annual)63.36%

Net Profit Margin (5Y Avg)28.91%

Cash / Share (Quarterly)$3.54

P/E Basic Excl Extra (TTM)8.90x

Revenue Growth QoQ (YoY)-29.70%

EPS Growth (5Y)-10.10%

P/E Normalized (Annual)15.00x

ROA (Last FY)-0.93%

Revenue Growth TTM (YoY)-10.07%

EBITD / Share (TTM)$1.88

ROE (5Y Avg)4.75%

Operating Margin (TTM)43.78%

Cash Flow / Share (Annual)$2.21

P/B Ratio0.82x

P/B Ratio (Quarterly)0.88x

Net Income / Employee (Annual)$-0

EV / Revenue (TTM)4.38x

Net Interest Coverage (TTM)2.58x

ROA (TTM)-0.86%

EPS Growth QoQ (YoY)159.25%

EV / EBITDA (TTM)7.93x

EPS Incl Extra (Annual)$-0.21

Current Ratio (Annual)9.41x

Quick Ratio (Quarterly)9.41x

3-Month Avg Trading Volume0.01M

52-Week Price Return-9.35%

EV / Free Cash Flow (Annual)6.79x

P/E Incl Extra (TTM)8.90x

Revenue / Employee (TTM)$5

Tangible BV / Share (Quarterly)$23.64

P/S Ratio (Annual)4.64x

Asset Turnover (Annual)0.15x

52-Week High$20.49

Operating Margin (5Y Avg)38.63%

EPS Excl Extra (Annual)$-0.21

CapEx CAGR (5Y)-33.51%

Tangible BV CAGR (5Y)6.42%

26-Week Price Return8.16%

Quick Ratio (Annual)9.41x

13-Week Price Return-7.13%

Total Debt / Equity (Annual)0.14x

Current Ratio (Quarterly)9.41x

Enterprise Value$181.673

Revenue / Share Growth (5Y)3.68%

Asset Turnover (TTM)0.14x

Book Value / Share Growth (5Y)0.68%

Revenue / Employee (Annual)$5

Inventory Turnover (Annual)8.05x

Pretax Margin (Annual)48.52%

Cash / Share (Annual)$3.54

3-Month Return Std Dev18.46%

Gross Margin (5Y Avg)70.46%

Net Income / Employee (TTM)$-0

EBITDA CAGR (5Y)0.99%

EBITDA Interim CAGR (5Y)-22.05%

ROE (Last FY)-1.08%

Net Interest Coverage (Annual)1.82x

EPS Basic Excl Extra (Annual)$-0.21

P/FCF (TTM)7.18x

Receivables Turnover (TTM)8.59x

EV / Free Cash Flow (TTM)6.79x

Total Debt / Equity (Quarterly)0.14x

EPS Incl Extra (TTM)$-0.22

Receivables Turnover (Annual)8.59x

ROI (TTM)-0.88%

P/S Ratio (TTM)4.64x

Pretax Margin (5Y Avg)41.93%

Revenue / Share (Annual)$3.41

Tangible BV / Share (Annual)$23.64

Forward P/E7.58x

Free OCF CAGR (5Y)11.80%

Price vs S&P 500 (52W)-25.52%

P/E Ratio (TTM)8.90x

EPS Growth TTM (YoY)119.11%

Year-to-Date Return-7.56%

5-Day Price Return-7.02%

EPS Normalized (Annual)$-0.21

ROA (5Y Avg)4.31%

Net Profit Margin (Annual)-6.11%

Month-to-Date Return-6.53%

Cash Flow / Share (TTM)$1.44

EBITD / Share (Annual)$1.88

EPS Growth (3Y)-18.80%

Operating Margin (Annual)43.78%

LT Debt / Equity (Annual)0.14x

P/CF (TTM)7.05x

ROI (5Y Avg)4.51%

P/E Excl Extra (TTM)8.90x

LT Debt / Equity (Quarterly)0.14x

EPS Basic Excl Extra (TTM)$-0.22

P/TBV (Quarterly)0.67x

P/B Ratio (Annual)0.88x

Pretax Margin (TTM)48.52%

Book Value / Share (Annual)$19.44

Price vs S&P 500 (13W)-2.59%

Net Margin Growth (5Y)-17.30%

Beta0.24x

P/FCF (Annual)7.18x

Revenue / Share (TTM)$3.43

ROE (TTM)-0.99%

52-Week Low$13.17

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

2.17

Industry Peers — Federal-Sponsored Credit Agencies(2)

Symbol	P/E Ratio (Annual)	ROE (TTM)	Operating Margin (TTM)	Revenue Growth (5Y)	Price
SWKHSWK Holdings Corporation	15.00x	-0.99%	43.78%	2.47%	$15.90
IXORIX Corporation American Depositary Shares (each representing One (1) Share of Common Stock)	14.92x	10.88%	13.14%	4.74%	$31.74
SWKHLSWK Holdings Corporation 9.00% Senior Notes due 2027	15.00x	-0.99%	43.78%	2.47%	$25.31

About

SWK Holdings Corp is a healthcare capital provider that finances life science companies and institutions by purchasing royalties and creating synthetic revenue interests from commercial-stage products and intellectual property. The company primarily generates revenue through its Finance Receivables segment, which monetizes cash flow streams from commercialized products. Through its subsidiary, SWK also provides non-discretionary investment advisory services to institutional clients.